LevoCept Overview

The LevoCept Intrauterine Contraceptive will soon be in a clinical study in the United States. It is limited by United States Federal Law to Investigational Use.

LevoCept is a levonorgestrel releasing intrauterine device intended to prevent pregnancy. LevoCept will soon be undergoing a Phase 2 Clinical Trial in the United States.

The LevoCept Difference

Properties of LevoCept intended to be investigated in the upcoming clinical study include:

  • Flexible shape memory frame
  • 52 mg of levonorgestrel
  • Smaller insertion profile
  • Pre-loaded Introducer
  • Pre-trimmed retrieval thread

Learn More About LevoCept

CAUTION: New Drug- Limited by Federal Law to Investigational Use.